Literature DB >> 6778381

In vitro activity of Ro 13-9904, cefuroxime, cefoxitin, and ampicillin against Neisseria gonorrhoeae.

T T Yoshikawa, S A Shibata, P Herbert, P A Oill.   

Abstract

In vitro susceptibilities of 87 isolates of non-penicillinase-producing Neisseria gonorrhoeae and 8 isolates of penicillinase-producing N. gonorrhoeae to Ro 13-9904, cefuroxime, cefoxitin, and ampicillin were determined. Ro 13-9904 was the most effective of the four drugs, inhibiting growth of both non-penicillinase-producing and penicillinase-producing N. gonorrhoeae.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6778381      PMCID: PMC283996          DOI: 10.1128/AAC.18.2.355

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  4 in total

1.  Susceptibility of Haemophilus influenza to ampicillin as determined by use of a modified, one-minute beta-lactamase test.

Authors:  J Escamilla
Journal:  Antimicrob Agents Chemother       Date:  1976-01       Impact factor: 5.191

2.  Cefuroxime, a beta-lactamase-resistant cephalosporin with a broad spectrum of gram-positive and -negative activity.

Authors:  H C Neu; K P Fu
Journal:  Antimicrob Agents Chemother       Date:  1978-04       Impact factor: 5.191

3.  Cefoxitin as a single-dose treatment for urethritis caused by penicillinase-producing Neisseria gonorrhoeae.

Authors:  S W Berg; M E Kilpatrick; W O Harrison; J A McCutchan
Journal:  N Engl J Med       Date:  1979-09-06       Impact factor: 91.245

4.  Comparison of in vitro susceptibility of Neisseria gonorrhoeae to trimethoprim-sulfamethoxazole on three different media.

Authors:  T T Yoshikawa; S Miyamoto; L B Guze
Journal:  Antimicrob Agents Chemother       Date:  1975-11       Impact factor: 5.191

  4 in total
  17 in total

Review 1.  A Brief History of Evolving Diagnostics and Therapy for Gonorrhea: Lessons Learned.

Authors:  Edward W Hook; Robert D Kirkcaldy
Journal:  Clin Infect Dis       Date:  2018-09-28       Impact factor: 9.079

2.  Randomised observer blind comparative trial of ceftriaxone and penicillin in treating uncomplicated gonorrhoea in men and women.

Authors:  C A Dixon; J B Bittiner; M Shahidullah; R C Slack; M Z Sulaiman
Journal:  Genitourin Med       Date:  1986-04

3.  In vitro activity of temocillin against Neisseria gonorrhoeae including penicillinase-producing strains.

Authors:  A E Jephcott; S I Egglestone
Journal:  Drugs       Date:  1985       Impact factor: 9.546

Review 4.  In vitro antibacterial effects of cephalosporins.

Authors:  J D Williams; F Moosdeen
Journal:  Drugs       Date:  1987       Impact factor: 9.546

5.  In vitro susceptibility of Haemophilus influenzae and neisseria gonorrhoeae to Ro 13-9904 in comparison with other beta-lactam antibiotics.

Authors:  W S Ng; P Y Chau; K Arnold
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

6.  Influence of inoculum size on comparative susceptibilities of penicillinase-positive and -negative Neisseria gonorrhoeae to 31 antimicrobial agents.

Authors:  W H Hall; B J Opfer
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

7.  The potential uses of ceftriaxone.

Authors:  W M Scheld
Journal:  Eur J Clin Microbiol       Date:  1983-10       Impact factor: 3.267

Review 8.  Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  D M Richards; R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-06       Impact factor: 9.546

9.  Comparative in-vitro activity of selected new beta-lactam antimicrobials against Neisseria gonorrhoeae.

Authors:  M Y Khan; Y Siddiqui; R P Gruninger
Journal:  Br J Vener Dis       Date:  1982-08

10.  Ceftriaxone: in vitro studies and clinical evaluation.

Authors:  J W Gnann; W E Goetter; A M Elliott; C G Cobbs
Journal:  Antimicrob Agents Chemother       Date:  1982-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.